Jun Ikari

987 total citations
50 papers, 701 citations indexed

About

Jun Ikari is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Jun Ikari has authored 50 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 7 papers in Molecular Biology. Recurrent topics in Jun Ikari's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers) and Pulmonary Hypertension Research and Treatments (7 papers). Jun Ikari is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers) and Pulmonary Hypertension Research and Treatments (7 papers). Jun Ikari collaborates with scholars based in Japan, United States and Germany. Jun Ikari's co-authors include Koichiro Tatsumi, Stephen I. Rennard, Masaki Suzuki, Joel Michalski, Naoko Kawata, Nozomi Tanaka, Ayako Shimada, Eiko Suzuki, Yuji Tada and Mitsuhiro Abe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.

In The Last Decade

Jun Ikari

49 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Ikari Japan 16 331 165 156 113 71 50 701
Noritaka Isowa Japan 18 438 1.3× 192 1.2× 61 0.4× 145 1.3× 80 1.1× 69 909
Tomoya Harada Japan 13 166 0.5× 110 0.7× 119 0.8× 84 0.7× 64 0.9× 49 511
Sarah Niccoli Canada 9 271 0.8× 127 0.8× 162 1.0× 74 0.7× 144 2.0× 20 613
Yukio Kawagishi Japan 15 232 0.7× 158 1.0× 388 2.5× 95 0.8× 52 0.7× 33 739
Yasuo To Japan 18 553 1.7× 199 1.2× 566 3.6× 218 1.9× 116 1.6× 49 1.1k
Sachiko Saeki Japan 15 248 0.7× 74 0.4× 331 2.1× 213 1.9× 99 1.4× 28 796
Daniel E. Bechard United States 13 255 0.8× 73 0.4× 47 0.3× 143 1.3× 122 1.7× 22 591
Kaoru Hamada Japan 18 317 1.0× 209 1.3× 312 2.0× 223 2.0× 94 1.3× 36 952
Eirini Vasarmidi Greece 14 541 1.6× 212 1.3× 116 0.7× 65 0.6× 80 1.1× 40 833
Po‐Chu Lee Taiwan 15 314 0.9× 152 0.9× 64 0.4× 74 0.7× 121 1.7× 61 845

Countries citing papers authored by Jun Ikari

Since Specialization
Citations

This map shows the geographic impact of Jun Ikari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Ikari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Ikari more than expected).

Fields of papers citing papers by Jun Ikari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Ikari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Ikari. The network helps show where Jun Ikari may publish in the future.

Co-authorship network of co-authors of Jun Ikari

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Ikari. A scholar is included among the top collaborators of Jun Ikari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Ikari. Jun Ikari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hara, Yu, Yasushi Obase, Shusaku Haranaga, et al.. (2024). Nationwide survey in Japan of the causative diseases of bloody sputum and hemoptysis in departments of respiratory medicine at university hospitals and core hospitals. Respiratory Investigation. 62(3). 395–401. 1 indexed citations
2.
Suzuki, Eiko, Naoko Kawata, Ayako Shimada, et al.. (2023). Prognostic Nutritional Index (PNI) as a Potential Prognostic Tool for Exacerbation of COPD in Elderly Patients. International Journal of COPD. Volume 18. 1077–1090. 11 indexed citations
3.
Abe, Mitsuhiro, Yuki Shiko, Kenji Tsushima, et al.. (2021). What are the factors affecting the recovery rate of bronchoalveolar lavage fluid?. The Clinical Respiratory Journal. 16(2). 142–151. 6 indexed citations
4.
Abe, Mitsuhiro, Kenji Tsushima, Daisuke Ishii, et al.. (2021). Risk Factors for Acute Exacerbation Following Bronchoalveolar Lavage in Patients with Suspected Idiopathic Pulmonary Fibrosis: A Retrospective Cohort Study. Advances in respiratory medicine. 89(2). 101–109. 5 indexed citations
5.
Shimada, Ayako, Naoko Kawata, Jun Ikari, et al.. (2021). Dynamic Quantitative Magnetic Resonance Imaging Assessment of Areas of the Lung During Free-Breathing of Patients with Chronic Obstructive Pulmonary Disease. Academic Radiology. 29. S215–S225. 11 indexed citations
6.
Suzuki, Masaki, Jun Ikari, Nozomi Tanaka, et al.. (2020). PAD4 Deficiency Improves Bleomycin-induced Neutrophil Extracellular Traps and Fibrosis in Mouse Lung. American Journal of Respiratory Cell and Molecular Biology. 63(6). 806–818. 97 indexed citations
7.
Ishiwata, Tsukasa, Jiro Terada, Mitsuhiro Abe, et al.. (2020). Feasibility and accuracy of rapid on-site evaluation of touch imprint cytology during transbronchial biopsy. Journal of Thoracic Disease. 12(6). 3057–3064. 12 indexed citations
8.
Abe, Mitsuhiro, Kenji Tsushima, Keiichiro Yoshioka, et al.. (2020). The Gender–Age–Physiology System as a Prognostic Model in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib: A Longitudinal Cohort Study. Advances in respiratory medicine. 88(5). 369–376. 3 indexed citations
9.
Kawata, Naoko, Yukiko Matsuura, Jun Ikari, et al.. (2019). Longitudinal changes in structural lung abnormalities using MDCT in chronic obstructive pulmonary disease with asthma-like features. PLoS ONE. 14(12). e0227141–e0227141. 4 indexed citations
10.
Fujimoto, Kazushi, Tsukasa Ishiwata, Hajime Kasai, et al.. (2018). Identification of factors during bronchoscopy that affect patient reluctance to undergo repeat examination: Questionnaire analysis after initial bronchoscopy. PLoS ONE. 13(12). e0208495–e0208495. 7 indexed citations
11.
Ikari, Jun, et al.. (2018). Tocilizumab-effective multicentric Castleman's disease with infiltration of eosinophil and IgG4-positive plasma cells: A case report. Respiratory Medicine Case Reports. 25. 25–29. 3 indexed citations
12.
Ogasawara, Takashi, Jun Ikari, Toshibumi Taniguchi, et al.. (2018). Allergic TH2 Response Governed by B-Cell Lymphoma 6 Function in Naturally Occurring Memory Phenotype CD4+ T Cells. Frontiers in Immunology. 9. 750–750. 3 indexed citations
13.
Tanaka, Nozomi, Takayuki Jujo, Toshihiko Sugiura, et al.. (2018). Partial anomalous pulmonary venous return with dual drainage to the superior vena cava and left atrium with pulmonary hypertension. Respiratory Medicine Case Reports. 25. 112–115. 1 indexed citations
14.
Abe, Mitsuhiro, Kenji Tsushima, Jun Ikari, et al.. (2017). Evaluation of the clinical characteristics of everolimus-induced lung injury and determination of associated risk factors. Respiratory Medicine. 134. 6–11. 4 indexed citations
15.
16.
Fujita, Tetsuo, Jun Ikari, Akira Watanabe, & Koichiro Tatsumi. (2016). Clinical characteristics of pulmonary nocardiosis in immunocompetent patients. Journal of Infection and Chemotherapy. 22(11). 738–743. 40 indexed citations
17.
Tada, Yuji, Toshio Suzuki, Naoko Kawata, et al.. (2015). Influence of pulmonary emphysema on COPD assessment test-oriented categorization in GOLD document. International Journal of COPD. 10. 1199–1199. 5 indexed citations
18.
Ikari, Jun, Joel Michalski, Shunichiro Iwasawa, et al.. (2013). Phosphodiesterase-4 Inhibition Augments Human Lung Fibroblast Vascular Endothelial Growth Factor Production Induced by Prostaglandin E2. American Journal of Respiratory Cell and Molecular Biology. 49(4). 571–581. 11 indexed citations
19.
Farid, Maha, Nobuhiro Kanaji, Masanori Nakanishi, et al.. (2013). Smad3 mediates cigarette smoke extract (CSE) induction of VEGF release by human fetal lung fibroblasts. Toxicology Letters. 220(2). 126–134. 21 indexed citations
20.
Michalski, Joel, et al.. (2011). PDE4: A Novel Target in the Treatment of Chronic Obstructive Pulmonary Disease. Clinical Pharmacology & Therapeutics. 91(1). 134–142. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026